In-vitro investigation regarding the effects of Gelucire® 44/14 and Labrasol® ALF on the secretory intestinal transport of P-gp substrates

被引:17
作者
Dubray, Oceane [1 ]
Jannin, Vincent [2 ]
Demarne, Frederic [2 ]
Pellequer, Yann [1 ]
Lamprecht, Alf [1 ,3 ]
Beduneau, Arnaud [1 ]
机构
[1] Univ Bourgogne Franche Comte, FDE EA4267, F-25000 Besancon, France
[2] Gattefosse SAS, 36 Chemin Genas, F-69804 St Priest, France
[3] Univ Bonn, Inst Pharm, Dept Pharmaceut, Bonn, Germany
关键词
Labrasol (R); Gelucire (R); P-glycoprotein; Permeability; Intestinal barrier; Caco-2/HT29-MTX co-culture; Digoxin; CACO-2 CELL MONOLAYERS; WATER-SOLUBLE DRUGS; GLYCOPROTEIN SUBSTRATE; MEDIATED TRANSPORT; ABSORPTION; EXCIPIENTS; BIOAVAILABILITY; ENHANCEMENT; INHIBITION; MODEL;
D O I
10.1016/j.ijpharm.2016.10.012
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this present study, the secretory transport of P-gp substrates, rhodamine 123 and digoxin, was evaluated using a Caco-2/HT29-MTX co-culture characterized by an efflux mechanism and a paracellular permeability closer to the human intestinal barrier compared to the Caco-2 monolayer gold standard. The influence of simulated intestinal fluids termed FeSSIF and FaSSIF on the intestinal absorption was also assessed in comparison with a conventional saline buffer. Labrasol (R) ALF and Gelucire (R) 44/14 in saline buffer significantly decreased to 83% and 62%, the P-gp-mediated transport of rhodamine 123 across the co-culture, respectively. The effects of Gelucire (R) 44/14 were much more exacerbated with the Caco-2 monolayer model with a reduced permeability to 34% but they were partially reversed in the co-culture with FeSSIF. The modulation by the lipid excipients of digoxin secretory transport across the Caco-2 monolayer and the co-culture was reduced compared with the rhodamine 123. This work also emphasizes the numerous parameters that have to be considered for predicting accurately the effects of potential P-gp inhibitors including the in-vitro model, the incubation media and the intrinsic properties of P-gp substrates. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:293 / 299
页数:7
相关论文
共 34 条
[1]   Differential metabolic responses to pluronic in MDR and non-MDR cells: A novel pathway for chemosensitization of drug resistant cancers [J].
Alakhova, Daria Yu. ;
Rapoport, Nataliya Y. ;
Batrakova, Elena V. ;
Timoshin, Alexander A. ;
Li, Shu ;
Nicholls, David ;
Alakhov, Valery Yu. ;
Kabanov, Alexander V. .
JOURNAL OF CONTROLLED RELEASE, 2010, 142 (01) :89-100
[2]   Biorelevant media resistant co-culture model mimicking permeability of human intestine [J].
Antoine, Delphine ;
Pellequer, Yann ;
Tempesta, Camille ;
Lorscheidt, Stefan ;
Kettel, Bernadette ;
Tamaddon, Lana ;
Jannin, Vincent ;
Demarne, Frederic ;
Lamprecht, Alf ;
Beduneau, Arnaud .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 481 (1-2) :27-36
[3]   Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats [J].
Bansal, Tripta ;
Mishra, Gautam ;
Jaggi, Manu ;
Khar, Roop K. ;
Talegaonkar, Sushama .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 36 (4-5) :580-590
[4]   A tunable Caco-2/HT29-MTX co-culture model mimicking variable permeabilities of the human intestine obtained by an original seeding procedure [J].
Beduneau, Arnaud ;
Tempesta, Camille ;
Fimbel, Stephane ;
Pellequer, Yann ;
Jannin, Vincent ;
Demarne, Frederic ;
Lamprecht, Alf .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2014, 87 (02) :290-298
[5]   Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs [J].
Cerpnjak, Katja ;
Zvonar, Alenka ;
Gasperlin, Mirjana ;
Vrecer, Franc .
ACTA PHARMACEUTICA, 2013, 63 (04) :427-445
[6]   Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo [J].
Cornaire, G ;
Woodley, J ;
Hermann, P ;
Cloarec, A ;
Arellano, U ;
Houin, G .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 278 (01) :119-131
[7]   Dissolution testing as a prognostic tool for oral drug absorption: Immediate release dosage forms [J].
Dressman, JB ;
Amidon, GL ;
Reppas, C ;
Shah, VP .
PHARMACEUTICAL RESEARCH, 1998, 15 (01) :11-22
[8]   REVERSAL OF MULTIDRUG-RESISTANCE PHENOTYPE BY SURFACTANTS - RELATIONSHIP TO MEMBRANE LIPID FLUIDITY [J].
DUDEJA, PK ;
ANDERSON, KM ;
HARRIS, JS ;
BUCKINGHAM, L ;
COON, JS .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1995, 319 (01) :309-315
[9]   In Vitro Gastrointestinal Lipolysis of Four Formulations of Piroxicam and Cinnarizine with the Self Emulsifying Excipients Labrasol® and Gelucire® 44/14 [J].
Fernandez, Sylvie ;
Chevrier, Stephanie ;
Ritter, Nicolas ;
Mahler, Bruno ;
Demarne, Frederic ;
Carriere, Frederic ;
Jannin, Vincent .
PHARMACEUTICAL RESEARCH, 2009, 26 (08) :1901-1910
[10]  
Hilgendorf C, 2000, J PHARM SCI-US, V89, P63, DOI 10.1002/(SICI)1520-6017(200001)89:1<63::AID-JPS7>3.0.CO